Vivian Ho,Marah N Short,Meei-Hsiang Ku-Goto
Vivian Ho
The empirical association between high hospital procedure volume and lower mortality rates has led to recommendations for the centralization of complex surgical procedures. Yet redirecting patients to a select number of high-volume hospital...
James J Fogarty
James J Fogarty
The 2010 Australian government tax review suggested Australia move to a uniform excise tax rate for all alcoholic beverages. Here, a model is presented and calibrated that shows the optimal per litre of pure alcohol (LAL) tax rates for beer...
The Distributional Effects of Health Reform Limits on Flexible Spending Accounts [0.03%]
美国健康改革中的保健灵活支出账户限制的分配效应分析
James H Cardon,Joel Moore,Mark H Showalter
James H Cardon
Flexible spending accounts (FSAs) are a widely used arrangement that allow employees to pay for qualified out-of-pocket health expenses with pre-tax dollars. The tax preference given to FSAs has been controversial and recent health care law...
Timothy J Richards,Lisa Mancino,William Nganje
Timothy J Richards
Food away from home (FAFH) and, specifically fast food, has been targeted by academics and public policy officials alike as a major contributor to the obesity epidemic. Criticized as high in energy, fat and sugars, the implication is that c...
Formal and Informal Care: An Empirical Bayesian Analysis Using the Two-part Model [0.03%]
基于两部模型的照料研究：经验贝叶斯分析方法
Juan Du
Juan Du
Informal care provided to the elderly by their children is proposed as a less expensive alternative to institutional long-term care. This paper explores how the elderly's consumption of medical care changes in response to changes in the inf...
Tomas J Philipson,Eric Sun,Dana Goldman et al.
Tomas J Philipson et al.
Recent evidence suggests that the economic value of increased health has been enormous, with most of these gains being driven by medical R&D. The R&D process for pharmaceuticals is particularly expensive and time consuming, with well-known ...
Michael R McKellar,Matthew Frank,Haiden Huskamp et al.
Michael R McKellar et al.
Despite bringing breakthrough medications to market, pharmaceutical companies incurred criticism during the 1990s and early 2000s because of high prices of many drugs. We argue that the benefits of pharmaceuticals should be evaluated in a d...
Julia Thornton Snider,John A Romley,William B Vogt et al.
Julia Thornton Snider et al.
Standard techniques of cost effectiveness analysis measure a technology's benefits in terms of expected life years (or quality-adjusted life years) gained at today's life expectancies. However, this approach ignores the gains which derive f...
Lorens A Helmchen,William E Encinosa,Michael E Chernew et al.
Lorens A Helmchen et al.
To rein in cost, payers are exploring bundled payment, which aggregates fees for a range of services into a single prospective payment. While under bundled payment providers would have incentives to reduce cost, they might also withhold mor...
The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis [0.03%]
新药上市对十五个经合组织国家的六十七种疾病住院率的影响：双向固定效应分析
Frank R Lichtenberg
Frank R Lichtenberg
There are two types of prescription drug cost offsets. The first type of cost offset - from prescription drug use - is primarily about the effect of changes in drug quantity (e.g. due to changes in out-of-pocket drug costs) on other medical...